Reducing Disparities in Urinary Control Symptoms for Minority Women
Launched by UNIVERSITY OF CHICAGO · Jan 28, 2025
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the SUPPORT program, is designed to help minority women who experience urinary incontinence (UI) and other related symptoms. The goal is to provide effective, culturally tailored treatments that these women can do at home. The program lasts for eight weeks and includes a mix of techniques such as behavioral therapy, exercise, and support from research staff. Participants will also have access to a special program that uses advanced technology to help them understand and follow the exercises and techniques.
To participate in the trial, women must be 18 years or older, identify as Black or Hispanic, and feel bothered by their urinary symptoms. They should be comfortable speaking in English and willing to commit to the program for four months. However, women with certain medical conditions or those currently receiving specific treatments for their symptoms may not be eligible. Throughout the study, participants will share their experiences and provide feedback to help improve future treatments for urinary issues.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Able to converse in English
- • A response of at least "somewhat bothered" by urinary incontinence, urinary frequency or urgency on the UDI
- • Willing to engage in conservative treatment of their UI/LUTS for 16 weeks
- Exclusion Criteria:
- • Anterior or posterior pelvic organ prolapse beyond the hymen or apical prolapse to the hymen
- • Currently taking medications for their UI/LUTS or history of surgical intervention for UI
- • Patients with abnormal PVR and positive urine culture at time of study entry
- • History of recurrent UTIs
- • History of mobility or neurologic disorders that would prevent ability to complete at home physical therapy
- • Planning to start PT within the next 16 weeks
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Chicago, Illinois, United States
Patients applied
Trial Officials
Kimberly Kenton, MD
Principal Investigator
University of Chicago
James Griffith, PhD
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported